SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009027
Filing Date
2022-05-10
Accepted
2022-05-10 16:39:36
Documents
17
Period of Report
2022-05-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20220509.htm   iXBRL 8-K 65226
2 EX-16.1 gls-ex16_1.htm EX-16.1 8553
3 GRAPHIC img18920380_0.jpg GRAPHIC 4961
4 GRAPHIC img18920380_1.jpg GRAPHIC 773
5 GRAPHIC img18920380_2.jpg GRAPHIC 1324
  Complete submission text file 0000950170-22-009027.txt   241317

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20220509_pre.xml EX-101.PRE 13102
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20220509_def.xml EX-101.DEF 13804
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20220509_lab.xml EX-101.LAB 17474
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20220509.xsd EX-101.SCH 3116
11 EXTRACTED XBRL INSTANCE DOCUMENT gls-20220509_htm.xml XML 6613
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 22910468
SIC: 2834 Pharmaceutical Preparations